International Assets Investment Management, LLC Biovie Inc. Transaction History

International Assets Investment Management, LLC

$1.06 Trillion
Q2 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Jan 30, 2023	BUY	$3.86 - $42.0 $40,530 - $441,000	10,500 New	10,500 $81,000

Others Institutions Holding BIVI

# of Institutions

Shares Held

4.79M

Call Options Held

17.2K

Put Options Held

27K

Altium Capital Management LP New York, NY

1.98M
Shares

$2.36 Million
0.42% of portfolio
Sabby Management, LLC Upper Saddle River, NJ

733K
Shares

$872,335
19.26% of portfolio
Vanguard Group Inc Valley Forge, PA

568K
Shares

$676,362
0.0% of portfolio
Swisspartners Ltd. Vaduz, N2

294K
Shares

$350,271
2.92% of portfolio
Geode Capital Management, LLC Boston, MA

232K
Shares

$275,670
0.0% of portfolio

View Full List

About BIOVIE INC.

Ticker BIVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,165,300
Market Cap $35.9M
Description
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...

More about BIVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.

Account